Todos Medical Ltd.
TOMDF · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $8 | $12 | $5 | $0 |
| % Growth | -37.1% | 134.9% | – | – |
| Cost of Goods Sold | $3 | $8 | $4 | $0 |
| Gross Profit | $4 | $4 | $1 | -$0 |
| % Margin | 56% | 35.8% | 26.7% | – |
| R&D Expenses | $1 | $1 | $10 | $1 |
| G&A Expenses | $0 | $9 | $3 | $3 |
| SG&A Expenses | $13 | $13 | $6 | $3 |
| Sales & Mktg Exp. | $0 | $3 | $3 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $14 | $14 | $16 | $4 |
| Operating Income | -$10 | -$9 | -$14 | -$4 |
| % Margin | -126.7% | -75.9% | -273.9% | – |
| Other Income/Exp. Net | -$15 | -$34 | -$16 | -$8 |
| Pre-Tax Income | -$25 | -$43 | -$30 | -$12 |
| Tax Expense | $0 | $0 | $0 | -$2 |
| Net Income | -$25 | -$43 | -$30 | -$10 |
| % Margin | -324.8% | -354.2% | -571.8% | – |
| EPS | -0.018 | -0.064 | -0.11 | -0.11 |
| % Growth | 72.5% | 42.1% | 0% | – |
| EPS Diluted | -0.018 | -0.064 | -0.11 | -0.11 |
| Weighted Avg Shares Out | 1,426 | 680 | 259 | 92 |
| Weighted Avg Shares Out Dil | 1,426 | 680 | 259 | 92 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $15 | $31 | $3 | $1 |
| Depreciation & Amortization | $1 | $1 | $0 | $0 |
| EBITDA | -$9 | -$10 | -$25 | -$8 |
| % Margin | -122.1% | -79.4% | -479.8% | – |